BDBM560832 (R)-2-((1s,4S)-4-(2-methylpyridin-4-yl)cyclohexyl)-N-(4-(pentafluoro-lambda6-sulfanyl)phenyl)propanamide::US11389445, Compound 3

SMILES C[C@H]([C@H]1CC[C@H](CC1)c1ccnc(C)c1)C(=O)Nc1ccc(cc1)S(F)(F)(F)(F)F

InChI Key InChIKey=MOTXANKDGGZDRL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 560832   

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM560832(US11389445, Compound 3 | (R)-2-((1s,4S)-4-(2-methy...)
Affinity DataIC50: 50nMAssay Description:The experimental principle is summarized as follows: IDO expression is low in Hela cells under no induction, but a certain concentration of IFN-γ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2022
Entry Details
US Patent